Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296

Mid-range Performer

Download real time

2016.80 -1.00 (-0.05%)

58.12% Gain from 52W Low

424.4K

NSE+BSE Volume

NSE 23 Sep, 2025 3:31 PM (IST)

Board Meeting

The next board meeting for Glenmark Pharmaceuticals Ltd. is on 26 Sep 2025 for the purpose of Interim Dividend See details

Glenmark Pharmaceuticals Ltd. News and Updates

Name: Latest research reports of Glenmark Pharmaceuticals Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Glenmark Pharmaceuticals Ltd.
Rating: 4
Author: Geojit BNP Paribas

Keep track of all breaking news on Glenmark Pharmaceuticals Ltd. from all sources in a single place.

Load latest

Is Glenmark Pharmaceuticals Ltd. worth buying?

571 Votes:

Buy 79.33%

Sell 13.66%

Hold 7.01%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf